
NASDAQ:TLRY
This summary was created by AI, based on 3 opinions in the last 12 months.
Tilray Inc. (TLRY-Q) is facing some significant challenges in its latest financial results. Reports indicate a decline in revenue, with the latest figure standing at $288M, reflecting a -6.6% change from the previous quarter, while previous reviews pointed to an even more alarming drop of -32% in prior results. This downward trend in revenue can raise concerns about demand for its products and may indicate potential difficulties within the market. Furthermore, gross profit has also seen a significant decline, registering a -14.9% change in the latest report and a drastic -38.1% change in past comparisons. On a somewhat positive note, there has been an increase in social media mentions by over 28% in the last 24 hours, suggesting heightened interest or speculation around the stock despite its current financial struggles. Overall, these factors highlight the need for further investigation into Tilray’s operational effectiveness and future growth prospects.
A lot of $$ was made, but now investors have come to realize marijuana is just a commodity. The company bears all the costs, but it has the federal/provincial government as a partner that shares equally in all the upside, but none of the down. Even advertising is restricted.
For a consumer stock, he holds Unilever.
So much wealth got destroyed in the cannabis sector, but Tilray will be one of the survivors. He can't offer a solid opinion about TLRY, because he needs to learn more about it, but he's starting to study the cannabis sector. Something will happen in the U.S. that will make banking for these companies allowable--and this will be a major move.
Tilray Inc. is a American stock, trading under the symbol TLRY (previously TLRY-Q on Stockchase) on the NASDAQ (TLRY). It is usually referred to as NASDAQ:TLRY or TLRY
In the last year, 3 stock analysts issued a Buy, Sell, or Hold rating on TLRY (previously TLRY-Q on Stockchase). 2 analysts recommended to BUY and 1 analyst recommended to SELL the stock. The latest stock analyst rating is DON'T BUY. Read the latest stock experts' ratings for Tilray Inc..
Tilray Inc. was recommended as a Top Pick by Darren Sissons on 2026-05-08. Read the latest stock experts ratings for Tilray Inc..
Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for Tilray Inc..
Tilray Inc. is followed by 90 investors on Stockchase and is a trending stock that is worth watching.
On 2026-07-14, Tilray Inc. (TLRY) stock closed at a price of $4.39.
Even with talk of rescheduling cannabis, US names offer significantly more upside than Canadian names. Look to the US if you want to take on this risk. If you own this one, use it as a tax loss.